Page last updated: 2024-08-21

isoxazoles and Substance Withdrawal Syndrome

isoxazoles has been researched along with Substance Withdrawal Syndrome in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19902 (12.50)18.7374
1990's5 (31.25)18.2507
2000's3 (18.75)29.6817
2010's5 (31.25)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Akinola, LS; Alkhlaif, Y; Bautista, MR; Carper, M; Chen, YC; Damaj, MI; Fowler, CD; Garai, S; Hamouda, AK; Jackson, A; Thakur, GA; Toma, WB1
Dunn, KE; Kim, C; Marcus, TF; Schroeder, JR; Umbricht, A; Vandrey, R1
Eglin, M; Hajak, G; Hedner, J; Loft, H; Lundahl, J; Lütolf, S; Stórustovu, SI1
Chang, JP; Huang, CC; Su, KP1
Alamo, C; Ferre, F; Jiménez-Arriero, MÁ; López-Muñoz, F; Martínez-Gras, I; Pascual, JM; Ponce, G; Rubio, G1
Huang, YC; Liang, CS; Yang, FW1
Campistol, J; Darling, A; Perez-Duenas, B; Poo, P1
Gong, QH; Gulinello, M; Smith, SS1
Cagetti, E; Liang, J; Olsen, RW; Spigelman, I1
Breese, GR; Frye, GD; McCown, TJ1
Dalby, JT; Dickson, R; Williams, R1
Byerly, MJ; Evans, DL; Greer, RA1
Zimbroff, DL1
Cott, J; Lieberman, JA; Matthews, S; Shore, D1
Arneric, SP; Brioni, JD; Buckley, MJ; Decker, MW; Kim, DJ; O'Neill, AB1
Zharkovskaia, TA; Zharkovskiĭ, AM1

Reviews

1 review(s) available for isoxazoles and Substance Withdrawal Syndrome

ArticleYear
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
    Revista de neurologia, 2013, Feb-01, Volume: 56, Issue:3

    Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid

2013

Trials

3 trial(s) available for isoxazoles and Substance Withdrawal Syndrome

ArticleYear
Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2016, Volume: 18, Issue:5

    Topics: Adult; Humans; Isoxazoles; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Zonisamide

2016
A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Sleep medicine, 2009, Volume: 10, Issue:7

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Electronic Data Processing; Female; GABA Agonists; Humans; Isoxazoles; Male; Middle Aged; Pyridines; Severity of Illness Index; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult; Zolpidem

2009
Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome.
    Pharmacopsychiatry, 2010, Volume: 43, Issue:7

    Topics: Adult; Alcoholism; Anticonvulsants; Diazepam; Dose-Response Relationship, Drug; Ethanol; Female; Humans; Isoxazoles; Male; Middle Aged; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult; Zonisamide

2010

Other Studies

12 other study(ies) available for isoxazoles and Substance Withdrawal Syndrome

ArticleYear
Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
    Neuropharmacology, 2021, 06-01, Volume: 190

    Topics: Allosteric Regulation; Animals; Behavior, Animal; Hydrocarbons, Brominated; Indole Alkaloids; Isoxazoles; Mice; Nicotine; Nicotinic Agonists; Protein Isoforms; Pyrazoles; Receptors, Nicotinic; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder

2021
Paliperidone overdose in a patient with schizophrenia.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, Mar-17, Volume: 34, Issue:2

    Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Schizophrenia; Substance Withdrawal Syndrome

2010
Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:5

    Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Parkinsonian Disorders; Psychotic Disorders; Pyrimidines; Substance Withdrawal Syndrome; Syndrome

2012
Progesterone withdrawal increases the anxiolytic actions of gaboxadol: role of alpha4betadelta GABA(A) receptors.
    Neuroreport, 2003, Jan-20, Volume: 14, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Drug Implants; Female; GABA Agonists; Hippocampus; Ion Channels; Isoxazoles; Maze Learning; Pentobarbital; Premenstrual Syndrome; Progesterone; Protein Isoforms; Protein Subunits; Rats; Receptors, GABA-A; Substance Withdrawal Syndrome

2003
Altered pharmacology of synaptic and extrasynaptic GABAA receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:3

    Topics: Alcoholism; Animals; Azides; Benzodiazepines; Diazepam; Drug Interactions; Ethanol; GABA Agonists; Hippocampus; Isoxazoles; Neurons; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Substance Withdrawal Syndrome; Zolpidem

2004
Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 226, Issue:3

    Topics: 4-Aminobutyrate Transaminase; Acoustic Stimulation; Aminobutyrates; Animals; Chlordiazepoxide; Disease Susceptibility; Ethanol; Forelimb; gamma-Aminobutyric Acid; Humans; Isoxazoles; Male; Muscimol; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Seizures; Substance Withdrawal Syndrome; Tremor

1983
Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:3

    Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Humans; Isoxazoles; Male; Neurologic Examination; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome

1994
Behavioral stimulation associated with risperidone initiation.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Anxiety; Benzodiazepines; Confusion; Female; Humans; Isoxazoles; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome

1995
Switching patients from clozapine to risperidone therapy.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Antipsychotic Agents; Clonazepam; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoxazoles; Lorazepam; Piperidines; Risperidone; Schizophrenia; Substance Withdrawal Syndrome

1995
Clinical implications of clozapine discontinuation: report of an NIMH workshop.
    Schizophrenia bulletin, 1995, Volume: 21, Issue:2

    Topics: Antipsychotic Agents; Clozapine; Drug Administration Schedule; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; United States; United States Food and Drug Administration

1995
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:1

    Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Cognition Disorders; Diazepam; Isoxazoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Substance Withdrawal Syndrome

1994
[Antiabstinent action of fenibut and baclofen on a model of abstinence induced by the benzodiazepine receptor antagonist CGS 8216 in rats receiving diazepam].
    Biulleten' eksperimental'noi biologii i meditsiny, 1987, Volume: 103, Issue:6

    Topics: Animals; Baclofen; Behavior, Animal; Diazepam; Drug Evaluation, Preclinical; gamma-Aminobutyric Acid; Isoxazoles; Male; Pyrazoles; Rats; Receptors, GABA-A; Substance Withdrawal Syndrome; Tranquilizing Agents

1987